Citi Pharma 1QFY27 profit rises 22% to Rs249m
Consolidated profit for the period of Citi Pharma Limited (PSX: CPHL) rose 22.14% year-on-year to Rs248.79m for the quarter ended September 30, 2026, compared with Rs203.69m in the same period last year.
November 02, 2026 (MLN): Consolidated profit for the period of Citi Pharma Limited (PSX: CPHL) rose 22.14% year-on-year to Rs248.79m for the quarter ended September 30, 2026, compared with Rs203.69m in the same period last year. Basic and diluted earnings per share (EPS) increased 22.47% to Rs1.09 from Rs0.89 in the corresponding quarter last year. The growth came from a 29.92% rise in gross profit and a 16.93% cut...